Diabetes is life long affliction that causes a person’s blood sugar level to become too high. With the two main types of diabetes, type 2 is far more common. Around 90% of all adults with diabetes have type 2.
Types
Type 2 is where the body is not creating enough insulin or the body is not reacting correctly to the insulin. This type usually requires the managing of medication, finding the right medication for each person can take time. Also many of the medications have side affects.
Type 1 is when the level of glucose in blood to be too high. This happens when the body isn’t producing enough of the hormone insulin which controls the levels of glucose in blood.
Both types are manageable with the correct advice and medication.
There are articles below that explore the condition in many different ways. Covering new research and evidence.
Around 20,000 children and young people with type 1 diabetes in England now benefit from life-changing 'artificial pancreas' technology, recommended by NICE.
Max Halford FBDO CL, Clinical Lead for the Association of British Dispensing Opticians, tells us what we need to know about Diabetic Retinal Screening in this eye health focus.
Researchers from Boston University, have found that incidents of racial discrimination are associated with lower subjective cognitive function (SCF) among African-American women.
A new study has shown that early signs of being prone to adult diabetes can be seen in children as young as 8 years old, decades before it is likely to be diagnosed.
Those newly diagnosed with Type 2 diabetes and heart failure are at the greatest 5-year risk of death, according to scientists at The American Heart Association.
Researchers from the University of North Carolina and NC State have developed artificial beta cells that automatically release insulin into the bloodstream when glucose levels rise, leading the way for new diabetes treatment.
Precision breeding has tailor-made new rice varieties designed to combat the double burden of malnutrition and a pesticide-free environment, according to Professor Dr Apichart Vanavichit from the Rice Science Center in Thailand.
In this article, our thoughts are directed towards understanding the Canadian Institutions of Health Research (CIHR) and The Institute of Nutrition, Metabolism and Diabetes (INMD).
Here, Dr Albert A. de Graaf discusses a novel predictive model-based decision support system to aid diabetes patients in the complex task of self-management.
